SLP Simulations Plus, Inc.

27.450.39 (+1.44%)
Close: June 18, 2019

Quote

Previous Close
$27.45
Day Range
$26.90-$27.50
52 Week Range
$16.70-$27.33
Volume
53,793
Avg Volume
46,100
Dividend TTM
$0.24 (0.89%)
Ex-Dividend Date
2019-04-23

Valuation

Market Cap
$480.79M
Enterprise Value (EV)
$464.56M
PE Ratio
64.57
EV/EBITDA
35.68
Price/Sales
15.98
Price/Book
15.06
PEG Ratio
0.77

Financials

Revenue
$29.67M
Gross Profit
$21.67M
EBITDA
$13.02M
EPS, ttm
$0.43
Profit Margin
30.12%
Revenue/Employee
$312.28K
Next Earnings Date
7/12/2019 (23 days)
Debt to Equity
-
Debt
-
Cash
$9.40M
Net Debt
-

Performance

Beta
1.05
200 Day Moving Avg
$20.92
50 Day Moving Avg
$23.83
52 Week Change
23.28%
YTD Change
37.42%
1 Month Change
9.96%
3 Month Change
31.55%
6 Month Change
44.01%
1 Year Change
23.28%
2 Year Change
86.02%
5 Year Change
284.72%

Share Count

Shares Outstanding
17.5M
Float
12.2M
Restricted Shares
5.3M
Restricted Shares, %
30.46%

Simulations Plus, Inc. Company Details

Sector: Technology Services

Industry: Packaged Software

CEO: Shawn M. O'Connor

Website: http://www.simulations-plus.com

Description: Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Employees: 95